Identification of Compounds with Nanomolar Binding Affinity for Checkpoint Kinase-1 Using Knowledge-Based Virtual Screening
Paul D. Lyne(AstraZeneca (South Korea)), Susan Ashwell(AstraZeneca (United Kingdom)), Peter W. Kenny(AstraZeneca (United Kingdom)), David A. Cosgrove(AstraZeneca (United Kingdom)), Sonya Zabludoff(AstraZeneca (United Kingdom)), Chun Deng(AstraZeneca (United Kingdom)), John J. Wendoloski(AstraZeneca (United States))
Cited by 112
Related Papers
A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases
|Journal of Combinatorial Chemistry|1998|3k
Structural Origins of High-Affinity Biotin Binding to Streptavidin
|Science|1989|1.2k
Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods
|The Journal of Physical Chemistry A|1998|794
Efficiency of signalling through cytokine receptors depends critically on receptor orientation
|Nature|1998|555
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
|Journal for ImmunoTherapy of Cancer|2018|286